BRCA1 and BRCA2 mutations are highly penetrant with a lifetime risk of 46–87% and 26–84% respectively of developing breast cancer by the age of 70 years for mutation carriers [4-8]. This evidence concerns the gene BRCA1 and breast carcinoma.